|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 29 studies with search of: | Paraneoplastic Syndromes |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Immunotherapy of the Paraneoplastic Syndromes
|
||||
| 2 | Completed |
Studies of Neurological Paraneoplastic Syndromes
|
||||
| 3 | Recruiting |
The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
|
||||
| 4 | Recruiting |
Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
|
||||
| 5 | Active, not recruiting |
Effectiveness of Rituximab in Pediatric OMS Patients.
|
||||
| 6 | Recruiting |
Use of 3, 4-Diaminopyridine in Lambert Eaton Myasthenic Syndrome
|
||||
| 7 | Available |
Treatment of Lambert-Eaton Syndrome With 3,4 DAP
|
||||
| 8 | Available |
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
|
||||
| 9 | Recruiting |
Open Label Trial Of 3,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome (LEMS)
|
||||
| 10 | Completed |
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
|
||||
| 11 | Active, not recruiting |
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
|
||||
| 12 | Recruiting |
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
|
||||
| 13 | Enrolling by invitation |
Ephedrine for the Treatment of Congenital Myasthenia
|
||||
| 14 | Active, not recruiting |
Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
|
||||
| 15 | Recruiting |
Biobank For MS And Other Demyelinating Diseases
|
||||
| 16 | Recruiting |
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
|
||||
| 17 | Recruiting |
Serum Auto-Antibodies
|
||||
| 18 | Active, not recruiting |
Safety and Tolerability of Rituximab in Neuromyelitis Optica
|
||||
| 19 | Completed |
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)
|
||||
| 20 | Completed |
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-29) |
|